Skip to main content

McLaughlin Kevin F's Form 4 filing

Acceleron Pharma Inc (XLRN) · filed Sep 24, 2021

Accession no.
0001179110-21-008935
Filed
Sep 24, 2021
Trade date
Sep 23-24, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 5 derivative transactions. Open-market sales total $4.01M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
McLaughlin Kevin FCIK 0001214938Officer (SVP, CFO and Treasurer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 23, 2021Common StockMOption exerciseAcquired+2,500$30.17+$75,42513,181Direct
Sep 23, 2021Common StockMOption exerciseAcquired+9,800$40.61+$397,97822,981Direct
Sep 23, 2021Common StockMOption exerciseAcquired+7,330$41.64+$305,221.230,311Direct
Sep 23, 2021Common StockSSaleDisposed−18,647$160.26−$2,988,368.2211,664Direct
Sep 23, 2021Common StockSSaleDisposed−983$161.26−$158,518.5810,681Direct
Sep 24, 2021Common StockMOption exerciseAcquired+5,200$40.61+$211,17215,881Direct
Sep 24, 2021Common StockMOption exerciseAcquired+170$41.64+$7,078.816,051Direct
Sep 24, 2021Common StockSSaleDisposed−5,370$160.38−$861,240.610,681Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 23, 2021Common StockMOption exerciseDisposed−2,500$0.00$02,663Direct
Sep 23, 2021Common StockMOption exerciseDisposed−9,800$0.00$016,462Direct
Sep 23, 2021Common StockMOption exerciseDisposed−7,330$0.00$020,670Direct
Sep 24, 2021Common StockMOption exerciseDisposed−5,200$0.00$011,262Direct
Sep 24, 2021Common StockMOption exerciseDisposed−170$0.00$020,500Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)